Vulcan Materials reports strong Q3 growth, expects 3% shipment rise and $2.4B EBITDA for 2025 amid infrastructure spending and favorable market conditions.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, highlighting intense competition in the obesity and GLP-1 asset market.
Vice President JD Vance hopes his Hindu-raised wife will embrace Christianity, sparking debate over religion, identity and public rhetoric.
Vulcan Materials reports strong Q3 growth, expects 3% shipment rise and $2.4B EBITDA for 2025 amid infrastructure spending and favorable market conditions.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, highlighting intense competition in the obesity and GLP-1 asset market.
Vice President JD Vance hopes his Hindu-raised wife will embrace Christianity, sparking debate over religion, identity and public rhetoric.